Clot-Busting Therapy Under Review, Case Western Reserve University Study

MONDAY, Sept. 28 (HealthDay News) -- Even as they digest the latest news on what dose of the clot-dissolving drug Plavix is best during angioplasty, cardiologists are looking at the next generation of clot-busters that could replace Plavix.

MORE ON THIS TOPIC